The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached? Read more about The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial. Read more about Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints. Read more about A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.
Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. Read more about Phase 2 trial design in neuro-oncology revisited: a report from the RANO group.
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Read more about Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types. Read more about Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types.
Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Read more about Breast cancer molecular profiling with single sample predictors: a retrospective analysis.
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Read more about Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
New insights into the role of HIV infection on cancer risk. Read more about New insights into the role of HIV infection on cancer risk.
